AF
TMO icon

Alerus Financial’s Thermo Fisher Scientific TMO Stock Holding History

Alerus Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.26M Sell
8,659
-497
-5% -$270K 0.21% 69
2025
Q4 		$5.31M Buy
9,156
+3,968
+76% +$2.24M 0.26% 62
2025
Q3 		$2.52M Buy
5,188
+3,106
+149% +$1.45M 0.13% 102
2025
Q2 		$844K Sell
2,082
-214
-9% -$89.5K 0.06% 116
2025
Q1 		$1.14M Sell
2,296
-93
-4% -$50.4K 0.09% 108
2024
Q4 		$1.24M Sell
2,389
-7,158
-75% -$3.94M 0.1% 102
2024
Q3 		$5.91M Buy
9,547
+1,055
+12% +$625K 0.43% 57
2024
Q2 		$4.7M Sell
8,492
-28
-0.3% -$16K 0.35% 66
2024
Q1 		$4.95M Sell
8,520
-232
-3% -$130K 0.37% 64
2023
Q4 		$4.65M Sell
8,752
-1,530
-15% -$741K 0.38% 66
2023
Q3 		$5.2M Sell
10,282
-746
-7% -$398K 0.46% 59
2023
Q2 		$5.75M Sell
11,028
-594
-5% -$321K 0.49% 59
2023
Q1 		$6.7M Buy
11,622
+30
+0.3% +$16.9K 0.6% 49
2022
Q4 		$6.38M Buy
11,592
+1,011
+10% +$536K 0.58% 45
2022
Q3 		$5.37M Buy
10,581
+3,602
+52% +$2.02M 0.53% 52
2022
Q2 		$3.79M Sell
6,979
-2,613
-27% -$1.44M 0.35% 68
2022
Q1 		$5.67M Buy
9,592
+242
+3% +$139K 0.48% 53
2021
Q4 		$6.24M Buy
9,350
+246
+3% +$154K 0.51% 40
2021
Q3 		$5.2M Sell
9,104
-88
-1% -$48.3K 0.47% 46
2021
Q2 		$4.64M Sell
9,192
-426
-4% -$201K 0.47% 55
2021
Q1 		$4.39M Sell
9,618
-758
-7% -$362K 0.46% 58
2020
Q4 		$4.83M Buy
10,376
+1,134
+12% +$532K 0.49% 52
2020
Q3 		$4.08M Sell
9,242
-4,908
-35% -$2.03M 0.46% 55
2020
Q2 		$5.13M Buy
14,150
+40
+0.3% +$13.4K 0.6% 41
2020
Q1 		$4M Buy
14,110
+1,937
+16% +$611K 0.55% 54
2019
Q4 		$3.96M Sell
12,173
-240
-2% -$72.8K 0.45% 65
2019
Q3 		$3.62M Sell
12,413
-224
-2% -$64.1K 0.47% 65
2019
Q2 		$3.71M Sell
12,637
-460
-4% -$127K 0.5% 54
2019
Q1 		$3.58M Sell
13,097
-136
-1% -$33.8K 0.5% 56
2018
Q4 		$2.96M Buy
+13,233
New +$3.1M 0.45% 60

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alerus Financial's TMO Position: Q1 2026 in Review

Alerus Financial reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q1 2026, selling an estimated $270K and leaving 8,659 shares worth $4.26M. The position accounts for 0.21% of the portfolio, ranked #69.

Alerus Financial first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.7M in Q1 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Alerus Financial held 8,659 shares of Thermo Fisher Scientific worth $4.26M as of Q1 2026.
  • Alerus Financial sold 497 Thermo Fisher Scientific shares in Q1 2026, an estimated $270K.
  • Thermo Fisher Scientific made up 0.21% of Alerus Financial's portfolio in Q1 2026, its #69 holding.
  • Alerus Financial first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Alerus Financial's Thermo Fisher Scientific position peaked at $6.7M in Q1 2023.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.